![Benoit Bouche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benoit Bouche
Vorstandsvorsitzender bei
Pacific Biomarkers, Inc.
Profil
Benoit Bouche is currently the Chief Executive Officer at Pacific Biomarkers, Inc., the President, Chief Executive Officer & Director at Nexelis Laboratories Canada, Inc., and the Operating Partner at Ampersand Management LLC.
He previously served as the President & Chief Executive Officer at NEOMED-LABS, Inc. and as an Analyst at Puilaetco in 2001.
Aktive Positionen von Benoit Bouche
| Unternehmen | Position | Beginn |
|---|---|---|
Pacific Biomarkers, Inc.
 Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Vorstandsvorsitzender | - |
Nexelis Laboratories Canada, Inc.
 Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Vorstandsvorsitzender | 01.01.2017 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Private Equity Investor | 01.04.2022 |
Ehemalige bekannte Positionen von Benoit Bouche
| Unternehmen | Position | Ende |
|---|---|---|
Puilaetco
 Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 05.12.2001 |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Puilaetco
Puilaetco Investment Banks/BrokersFinance Provides brokerage services | Finance |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pacific Biomarkers, Inc.
Pacific Biomarkers, Inc. Medical SpecialtiesHealth Technology Provides biomarker testing services | Health Technology |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Health Technology |
Wählen Sie MarketScreener 
